	Radiotherapy dose escalation for the non-operative management of patients with unresectable locally recurrent rectal cancer (STEP-UP): Study protocol for a multicentre, prospective, open-label feasibility study. Clin Transl Radiat Oncol Vande Kerckhove FEC, Beeftink JL, Tijssen RHN, Zijlstra J, Verrijssen AE, van Kuijk SMJ, van Ravensteijn SG, van Hellemond IEG, Calon TGA, Werter IM, Couwenberg AM, Schuurhuizen CSEW, den Hartogh MD, Hendriksen EM, Hupkens B, Buijsen J, Berbée M, Intven MPW, Bloemen JG, Nederend J, Burger JWA, Peulen HMU. PMID: 42927245 [PubMed]
	Prognostic Significance and Clinical Robustness of the HALP Score in Super-Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer: A Multicenter Retrospective Cohort Study. Ann Gastroenterol Surg Inoue H, Kubota T, Kosuga T, Nishibeppu K, Sumiyoshi S, Hamada J, Takabatake K, Katsurahara K, Ariyoshi Y, Miyagawa K, Sai S, Itokawa Y, Hatakeyama T, Ochi F, Konishi H, Fujiwara H, Shiozaki A. PMID: 42927056 [PubMed - as supplied by publisher]
	Impact of direct transfer to critical care on mortality for patients who undergo emergency colorectal cancer resection: a national population-based cohort study in England. BJA Open Blake HA, Rashid A, Watton L, Kuryba A, Boyle JM, Vallance A, Berkman L, Harrison DA, Doidge J, Moonesinghe SR, Murray D, Hill J, Fearnhead NS, van der Meulen J, Sharples LD, Walker K. PMID: 42926795 [PubMed]
	Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles. Discov Oncol Broni FK, George BP, Abrahamse H. PMID: 42926737 [PubMed]
	Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S. PMID: 42926595 [PubMed]
	A randomized Phase 1 study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine-tipiracil with bevacizumab in patients with metastatic colorectal cancer. Ann Oncol Cecchini M, Cruz-Correa M, Han SW, Raghav K, Landa-Magdalena A, Strickler JH, Calvo A, Hollebecque A, Nakajima TE, Perl G, Jain V, Hunter Z, Chan EM, Blaney M, Li R, Vasilopoulos A, Parikh A, Sharma MR. PMID: 42926107 [PubMed - as supplied by publisher]
	Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW. Ann Oncol Lonardi S, Lenz HJ, Elez E, Jensen LH, Van Cutsem E, Touchefeu Y, García-Carbonero R, Tougeron D, Mendez GA, Schenker M, Fouchardière C, Mirón MLL, Yoshino T, Li J, Mozo JLM, Dahan L, Tortora G, Chalabi M, Goekkurt E, Braghiroli MI, Joshi R, Cil T, Aubin F, Raparthi V, Wang A, Rodriguez S, Cela E, Li L, Tam R, Jin L, André T. PMID: 42926106 [PubMed - as supplied by publisher]
	14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan. Lancet Sakakida T, Taniguchi H, Asayama M, Suwa Y, Shimura T, Mitani S, Makiyama A, Arai H, Matsuoka H, Yokota M, Takano Y, Kato K, Oda H, Kajiwara T, Ogawa K, Shibata N, Sawada K, Yomoda T, Kudo T, Okuda H, Okumura Y, Tanaka C, Nakamura M, Tsuda T, Kitajima T, Tsukuda H, Shinozaki E, Furuta M, Kashiwada T, Okuya K, Mushiake H, Hasegawa J, Nihei K, Mizushima T, Mine T, Mizukami T, Kudo C, Mishima A, Murotani K, Masuishi T, PRABITAS investigators. PMID: 42925880 [PubMed - as supplied by publisher]
	Descriptive survival outcomes of fruquintinib-based PD-1 inhibitor strategies in advanced colorectal cancer reported as pMMR/MSS: a reconstructed-data analysis of prospective studies. Cancer Treat Res Commun Ge Y, Xia Y, Lin GH, Fu C, Kuang BH, Wang BC. PMID: 42925845 [PubMed - as supplied by publisher]
	Incorporating visceral adipose tissue into dual-region deep learning radiomics on CT improves preoperative lymph node metastasis prediction in gastric cancer: A multicenter study. Eur J Radiol Miao S, Xiong Z, Yang H, Zhang L, Qi H, Liu Z, Wang Q, Ding X, Wang R, Lu P. PMID: 42925841 [PubMed - as supplied by publisher]
	Japanese Society for Hereditary Tumors Guidance: Hereditary Cancer Syndromes With Multigene Panel Testing, 2025 Edition. Cancer Sci Yoshida R, Hirasawa A, Imoto I, Yamaguchi T, Kumamoto K, Momoko A, Ueki A, Masuda K, Urakawa Y, Tanabe N, Watanabe A, Hirata M, Aruga T, Kuwata T, Okugawa Y, Kaneko K, Terui-Kohbata H, Matsumoto M, Ueno S, Oda K, Ono H, Sakurai A, Matsui H, Yamamoto G, Yamamoto H, Yamamoto Y, Ikegami M, Ohkuma Y, Shien K, Suzuki S, Takayanagi S, Tanabe M, Hasumi H, Hatta N, Hattori H, Matsubayashi H, Yamagami W, Yamada M, Oishi K, Oka T, Oda S, Kobayashi Y, Takekoshi K, Nakajima T, Nakano Y, Nakayama Y, Miura F, Miyakura Y, Mori Y, Yoshimura A, Yonamine M, Shigeyasu K, Fujita H, Futagawa M, Ohta K, Kawano J, Tokutomi T, Sato A, Makabe T, Yoshihama T, Aitani M, Kimura K, Takaiso N, Tomozawa C, Hiraoka Y, Matsukawa M, Ishida H. PMID: 42925246 [PubMed - as supplied by publisher]
	Multimodal prehabilitation in colorectal cancer surgery: randomized clinical trial. BJS Open Bjerregaard F, Pekkari K, Asklid D, Anderin C, Westberg K, Marsk R, Gustafsson UO. PMID: 42925093 [PubMed - indexed for MEDLINE]
	Measures of physical fitness and postoperative mortality in patients with colorectal cancer: national cohort study. BJS Open Rashid A, Blake HA, Watton L, Fearnhead NS, Han L, van der Meulen J, Walker K. PMID: 42925090 [PubMed - indexed for MEDLINE]
	Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeuticÂ implications (Review). Int J Mol Med Zhang T, Ren Z, Wang L, Man R, Wang L, Wang J, Cheng X, Peng J, Yu Y. PMID: 42924590 [PubMed - indexed for MEDLINE]
	The Economic Value of Hereditary Cancer Testing: A Systematic Review. Genet Med Kirshner C, Carter GC, Heald B, Hartzfeld D, Johnson H, Xiao J, Kong J, Thompson G, Sancar F, Peters ML. PMID: 42924496 [PubMed - as supplied by publisher]
	Integrative Untargeted Metabolomics, Network Pharmacology, and Molecular Docking Identify Candidate Anti-Gastric Cancer Mechanisms of Zhishi Dahuang Decoction. Biomed Chromatogr Zhang L, Zhao X, Shi B, Zhou N, Xiong D, Chen X, Ji L, Shen Q, Lv Y. PMID: 42924494 [PubMed - indexed for MEDLINE]
	Robot-assisted radical surgery for colorectal cancer: technical advances, lymphadenectomy, natural orifice specimen extraction, and ongoing controversies. Front Surg Liu W, Ma Z, Xie J, Wu X, Baheen QA, Zhang S, Liu Z. PMID: 42924242 [PubMed]
	Routes to Diagnosis and Stage at Diagnosis of Colorectal Cancer in Patients Aged â‰¥ 50 Years: A Multicentre Retrospective Cohort Study From North Wales, UK. Cureus Toquero M, Thiagarajah Naidu S, Williams AD, Waddon J, Emmas R, Das A, Noor A, Balasubaramaniam V, Dixon S. PMID: 42923923 [PubMed]
	Serum metabolomic signatures associated with gastric signet-ring cell carcinoma: A dual-platform mass spectrometry study. Oncol Lett Cao H, Guo S, Li J, Bian Y, Shen J, Wang J, Meng F, Sun W, Sun Q, Gu W. PMID: 42923593 [PubMed]
	Efficacy and safety of postoperative chemotherapy with capecitabine and oxaliplatin for advanced gastric cancer. Am J Transl Res Wang J, Li Y, Wang H, Cai X. PMID: 42923190 [PubMed]

Articles 1 - 20 / 246463

Page 1 of 12324



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy